Swiss Association for the Verification of Medicinal Products
Counterfeit protection for medicines
The aim of Delegated Regulation (EU) 2016/161 is to provide reliable protection for medicinal products against counterfeiting. This will be achieved with new identification and safety features for pharmaceutical packaging and a comprehensive database system for all EU and EEA member states.
Since February 9, 2019, national systems for the verification of unique identifiers have been in operation in almost all EEA countries. This verification works across national borders, preventing the introduction of falsified medicinal products into the legal supply chain.
The legal situation in Switzerland
The adoption of the motion by Councillor of States Erich Ettlin 22.3859 "Master plan for digital transformation in the healthcare sector. Use of legal standards and existing data" of 26.9.2023 by the Federal Parliament, the affixing and verification of safety features and devices on the packaging of prescription-only medicinal products for human use was declared mandatory.
You can find out more about the legal situation here.
